- Home
- RLMD vs RLTY Comparison
RLMD vs RLTY Comparison
Compare RLMD & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLMD | RLTY |
|---|---|---|
| Founded | 2004 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.3M | 247.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RLMD | RLTY |
|---|---|---|
| Price | $4.31 | $14.54 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 86.7K |
| Earning Date | 11-13-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.35% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $11.38 |
| 52 Week High | $5.12 | $14.60 |
Technical Indicators
Market Signals| Indicator | RLMD | RLTY |
|---|---|---|
| Relative Strength Index (RSI) | 60.68 | 35.15 |
| Support Level | $3.95 | $14.53 |
| Resistance Level | $4.72 | $14.78 |
| Average True Range (ATR) | 0.45 | 0.19 |
| MACD | -0.08 | -0.03 |
| Stochastic Oscillator | 58.82 | 1.51 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.